KR102142255B1
|
|
Expression Method of CRM197 Protein
|
KR102099342B1
|
|
Expression Method of CRM197 Protein
|
KR20200141734A
|
|
Recombinant Microorganism Having Enhanced Phytofluene Producing Ability and Method for Preparing Phytofluene Using the Same
|
KR20200122006A
|
|
Recombinant Microorganism Having Enhanced Menaquinone-7 Producing Ability and Method for Preparing Menaquinone-7 Using the Same
|
KR102030033B1
|
|
Bacillus circulans Varient Strain with Increased Beta-galactosidase Productivity
|
KR20200027624A
|
|
COMPOSITION FOR PREVENTING OR TREATING Inflammatory Bowl Disease
|
KR101840306B1
|
|
Composition for preventing or treating hyperlipidemia
|
KR101814035B1
|
|
Composition having anti-inflammatory and anti-oxidant activity comprising sod derived from bacillus amyloliquefaciens strain
|
KR101762199B1
|
|
Polypeptides with superoxide dismutase activity derived from bacillus amyloliquefaciens and preparation method thereof
|
KR20170029471A
|
|
Fully active beta-galactosidase mutants and Uses thereof
|
KR20160134618A
|
|
New Lipase Signal Sequences and Expression Method Using The Same
|
KR20160134619A
|
|
New Lipase Signal Sequences and Expression Method Using The Same
|
KR20170009112A
|
|
Novel alpha-1,3-glucanse
|
KR20160141123A
|
|
Fully active beta-galactosidase mutants and Uses thereof
|
KR20160043165A
|
|
Extracellular production of proteins in Bacillus host
|
KR20150136729A
|
|
New Catalase Signal Sequences and Expression Method Using The Same
|
KR20150136730A
|
|
New Lipase Signal Sequences and Expression Method Using The Same
|
KR20150136728A
|
|
Method for Expressing High-Level of Target Protein by Gene Silencing
|
KR20150135701A
|
|
NOVEL β-GLACTOSIDASE
|
KR20100096569A
|
|
Novel beta-galactosidase having high-transglycosylation activity and use thereof
|